Hansa Biopharma AB (publ)
Hansa Biopharma AB (publ) 0RC7.L Peers
See (0RC7.L) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0RC7.L | $84.70 | -18.94% | 1.86B | N/A | N/A | N/A |
| 0QW0.L | $352.20 | -1.36% | 13.37B | -31.93 | -$11.03 | N/A |
| 0A8K.L | $31.24 | +0.03% | 8.26B | -53.04 | -$0.59 | N/A |
| 0H22.L | $44.54 | N/A | 2.24B | -9.78 | -$4.56 | N/A |
| 0HI3.L | $14.01 | +7.16% | 1.92B | -13.03 | -$1.08 | N/A |
| GNS.L | $2,120.00 | +0.47% | 1.39B | -353.33 | -$0.06 | +1.51% |
| 0RC6.L | $73.87 | N/A | 1.35B | 14.69 | $5.03 | +0.86% |
| ONT.L | $134.30 | +4.51% | 1.29B | -8.39 | -$0.16 | N/A |
| 0K1R.L | $12.98 | +3.82% | 1.06B | -2.53 | -$5.14 | N/A |
| 0RHR.L | $23.07 | -3.47% | 844.80M | -100.30 | -$0.23 | N/A |
Stock Comparison
0RC7.L vs 0QW0.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0QW0.L has a market cap of 13.37B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0QW0.L trades at $352.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0QW0.L's P/E ratio is -31.93. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0QW0.L's ROE of +0.17%. Regarding short-term risk, 0RC7.L is more volatile compared to 0QW0.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0A8K.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0A8K.L has a market cap of 8.26B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0A8K.L trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0A8K.L's P/E ratio is -53.04. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0A8K.L's ROE of +0.05%. Regarding short-term risk, 0RC7.L is more volatile compared to 0A8K.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0H22.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0H22.L has a market cap of 2.24B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0H22.L trades at $44.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0H22.L's P/E ratio is -9.78. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0H22.L's ROE of -0.50%. Regarding short-term risk, 0RC7.L is more volatile compared to 0H22.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0HI3.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0HI3.L has a market cap of 1.92B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0HI3.L trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0HI3.L's P/E ratio is -13.03. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0HI3.L's ROE of -2.43%. Regarding short-term risk, 0RC7.L is more volatile compared to 0HI3.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs GNS.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, GNS.L has a market cap of 1.39B. Regarding current trading prices, 0RC7.L is priced at $84.70, while GNS.L trades at $2,120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas GNS.L's P/E ratio is -353.33. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to GNS.L's ROE of -0.01%. Regarding short-term risk, 0RC7.L is more volatile compared to GNS.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0RC6.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0RC6.L has a market cap of 1.35B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0RC6.L trades at $73.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0RC6.L's P/E ratio is 14.69. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0RC6.L's ROE of +0.10%. Regarding short-term risk, 0RC7.L is less volatile compared to 0RC6.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ONT.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ONT.L has a market cap of 1.29B. Regarding current trading prices, 0RC7.L is priced at $84.70, while ONT.L trades at $134.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ONT.L's P/E ratio is -8.39. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ONT.L's ROE of -0.25%. Regarding short-term risk, 0RC7.L is less volatile compared to ONT.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0K1R.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0K1R.L has a market cap of 1.06B. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0K1R.L trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0K1R.L's P/E ratio is -2.53. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0K1R.L's ROE of -0.43%. Regarding short-term risk, 0RC7.L is more volatile compared to 0K1R.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0RHR.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0RHR.L has a market cap of 844.80M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0RHR.L trades at $23.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0RHR.L's P/E ratio is -100.30. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0RHR.L's ROE of -0.07%. Regarding short-term risk, 0RC7.L is more volatile compared to 0RHR.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0A8E.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0A8E.L has a market cap of 783.96M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0A8E.L trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0A8E.L's P/E ratio is -3.46. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0A8E.L's ROE of +2.54%. Regarding short-term risk, 0RC7.L is less volatile compared to 0A8E.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ERGO.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ERGO.L has a market cap of 771.71M. Regarding current trading prices, 0RC7.L is priced at $84.70, while ERGO.L trades at $1,348.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ERGO.L's P/E ratio is 48.14. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ERGO.L's ROE of +0.20%. Regarding short-term risk, 0RC7.L is more volatile compared to ERGO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0AAJ.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0AAJ.L has a market cap of 660.75M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0AAJ.L trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0AAJ.L's P/E ratio is 13.39. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0AAJ.L's ROE of -0.05%. Regarding short-term risk, 0RC7.L is more volatile compared to 0AAJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0RQE.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0RQE.L has a market cap of 334.58M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0RQE.L trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0RQE.L's P/E ratio is -2.68. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0RQE.L's ROE of +0.24%. Regarding short-term risk, 0RC7.L is more volatile compared to 0RQE.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OXB.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OXB.L has a market cap of 312.69M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OXB.L trades at $295.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OXB.L's P/E ratio is -7.02. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OXB.L's ROE of -0.70%. Regarding short-term risk, 0RC7.L is less volatile compared to OXB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs PRTC.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, PRTC.L has a market cap of 295.91M. Regarding current trading prices, 0RC7.L is priced at $84.70, while PRTC.L trades at $123.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas PRTC.L's P/E ratio is 7.70. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to PRTC.L's ROE of +0.15%. Regarding short-term risk, 0RC7.L is less volatile compared to PRTC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs FARN.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, FARN.L has a market cap of 245.52M. Regarding current trading prices, 0RC7.L is priced at $84.70, while FARN.L trades at $220.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas FARN.L's P/E ratio is -8.80. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to FARN.L's ROE of +0.01%. Regarding short-term risk, 0RC7.L is less volatile compared to FARN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0I0X.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0I0X.L has a market cap of 216.98M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0I0X.L trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0I0X.L's P/E ratio is -8.24. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0I0X.L's ROE of -0.93%. Regarding short-term risk, 0RC7.L is more volatile compared to 0I0X.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ARIX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ARIX.L has a market cap of 183.73M. Regarding current trading prices, 0RC7.L is priced at $84.70, while ARIX.L trades at $142.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ARIX.L's P/E ratio is 12.91. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ARIX.L's ROE of -0.11%. Regarding short-term risk, 0RC7.L is more volatile compared to ARIX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 4BB.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 4BB.L has a market cap of 174.06M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 4BB.L trades at $1,125.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 4BB.L's P/E ratio is -14.42. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 4BB.L's ROE of +3.45%. Regarding short-term risk, 0RC7.L is more volatile compared to 4BB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs BVXP.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, BVXP.L has a market cap of 148.91M. Regarding current trading prices, 0RC7.L is priced at $84.70, while BVXP.L trades at $2,850.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas BVXP.L's P/E ratio is 19.26. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to BVXP.L's ROE of +0.67%. Regarding short-term risk, 0RC7.L is more volatile compared to BVXP.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs AVCT.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, AVCT.L has a market cap of 126.54M. Regarding current trading prices, 0RC7.L is priced at $84.70, while AVCT.L trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas AVCT.L's P/E ratio is -3.67. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to AVCT.L's ROE of -0.74%. Regarding short-term risk, 0RC7.L is less volatile compared to AVCT.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs HVO.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, HVO.L has a market cap of 118.51M. Regarding current trading prices, 0RC7.L is priced at $84.70, while HVO.L trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas HVO.L's P/E ratio is 8.63. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to HVO.L's ROE of +0.42%. Regarding short-term risk, 0RC7.L is less volatile compared to HVO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs SCLP.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, SCLP.L has a market cap of 98.49M. Regarding current trading prices, 0RC7.L is priced at $84.70, while SCLP.L trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas SCLP.L's P/E ratio is -4.75. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to SCLP.L's ROE of +1.66%. Regarding short-term risk, 0RC7.L is less volatile compared to SCLP.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0HTC.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0HTC.L has a market cap of 81.08M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0HTC.L trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0HTC.L's P/E ratio is -2.96. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0HTC.L's ROE of -7.56%. Regarding short-term risk, 0RC7.L is less volatile compared to 0HTC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs REDX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, REDX.L has a market cap of 58.35M. Regarding current trading prices, 0RC7.L is priced at $84.70, while REDX.L trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas REDX.L's P/E ratio is -1.50. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to REDX.L's ROE of -1.81%. Regarding short-term risk, 0RC7.L is more volatile compared to REDX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ETX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ETX.L has a market cap of 56.39M. Regarding current trading prices, 0RC7.L is priced at $84.70, while ETX.L trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ETX.L's P/E ratio is -4.50. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ETX.L's ROE of -0.45%. Regarding short-term risk, 0RC7.L is more volatile compared to ETX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs SBTX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, SBTX.L has a market cap of 46.81M. Regarding current trading prices, 0RC7.L is priced at $84.70, while SBTX.L trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas SBTX.L's P/E ratio is -20.00. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to SBTX.L's ROE of -0.69%. Regarding short-term risk, 0RC7.L is less volatile compared to SBTX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OBI.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OBI.L has a market cap of 39.00M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OBI.L trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OBI.L's P/E ratio is -2.93. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OBI.L's ROE of -6.84%. Regarding short-term risk, 0RC7.L is more volatile compared to OBI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs MTPH.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, MTPH.L has a market cap of 31.20M. Regarding current trading prices, 0RC7.L is priced at $84.70, while MTPH.L trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas MTPH.L's P/E ratio is -0.22. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to MTPH.L's ROE of -1.12%. Regarding short-term risk, 0RC7.L is more volatile compared to MTPH.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs C4XD.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, C4XD.L has a market cap of 30.27M. Regarding current trading prices, 0RC7.L is priced at $84.70, while C4XD.L trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas C4XD.L's P/E ratio is 3.00. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to C4XD.L's ROE of +0.68%. Regarding short-term risk, 0RC7.L is more volatile compared to C4XD.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs FUM.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, FUM.L has a market cap of 26.77M. Regarding current trading prices, 0RC7.L is priced at $84.70, while FUM.L trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas FUM.L's P/E ratio is -8.81. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to FUM.L's ROE of +0.15%. Regarding short-term risk, 0RC7.L is less volatile compared to FUM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs SAR.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, SAR.L has a market cap of 23.52M. Regarding current trading prices, 0RC7.L is priced at $84.70, while SAR.L trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas SAR.L's P/E ratio is -5.83. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to SAR.L's ROE of -0.64%. Regarding short-term risk, 0RC7.L is less volatile compared to SAR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OKYO.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OKYO.L has a market cap of 23.22M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OKYO.L trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OKYO.L's P/E ratio is -1.40. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OKYO.L's ROE of -1.36%. Regarding short-term risk, 0RC7.L is more volatile compared to OKYO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs TRX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, TRX.L has a market cap of 23.15M. Regarding current trading prices, 0RC7.L is priced at $84.70, while TRX.L trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas TRX.L's P/E ratio is -32.50. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to TRX.L's ROE of -0.03%. Regarding short-term risk, 0RC7.L is more volatile compared to TRX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0RA2.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0RA2.L has a market cap of 20.92M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0RA2.L trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0RA2.L's P/E ratio is -1.93. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0RA2.L's ROE of +0.32%. Regarding short-term risk, 0RC7.L is less volatile compared to 0RA2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0V43.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0V43.L has a market cap of 20.72M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0V43.L trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0V43.L's P/E ratio is -1.37. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0V43.L's ROE of -1.25%. Regarding short-term risk, 0RC7.L is more volatile compared to 0V43.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs IMM.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, IMM.L has a market cap of 18.49M. Regarding current trading prices, 0RC7.L is priced at $84.70, while IMM.L trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas IMM.L's P/E ratio is -3.70. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to IMM.L's ROE of -0.66%. Regarding short-term risk, 0RC7.L is less volatile compared to IMM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OPTI.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OPTI.L has a market cap of 18.12M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OPTI.L trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OPTI.L's P/E ratio is -6.17. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OPTI.L's ROE of -0.37%. Regarding short-term risk, 0RC7.L is more volatile compared to OPTI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs AREC.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, AREC.L has a market cap of 15.86M. Regarding current trading prices, 0RC7.L is priced at $84.70, while AREC.L trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas AREC.L's P/E ratio is -1.35. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to AREC.L's ROE of -1.96%. Regarding short-term risk, 0RC7.L is less volatile compared to AREC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs POLB.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, POLB.L has a market cap of 14.25M. Regarding current trading prices, 0RC7.L is priced at $84.70, while POLB.L trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas POLB.L's P/E ratio is -2.85. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to POLB.L's ROE of -0.33%. Regarding short-term risk, 0RC7.L is less volatile compared to POLB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0HUZ.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0HUZ.L has a market cap of 12.87M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0HUZ.L trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0HUZ.L's P/E ratio is -0.22. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0HUZ.L's ROE of -3.02%. Regarding short-term risk, 0RC7.L is less volatile compared to 0HUZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs NSCI.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, NSCI.L has a market cap of 12.72M. Regarding current trading prices, 0RC7.L is priced at $84.70, while NSCI.L trades at $53.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas NSCI.L's P/E ratio is -4.83. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to NSCI.L's ROE of N/A. Regarding short-term risk, 0RC7.L is more volatile compared to NSCI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs SNG.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, SNG.L has a market cap of 11.58M. Regarding current trading prices, 0RC7.L is priced at $84.70, while SNG.L trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas SNG.L's P/E ratio is -0.47. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to SNG.L's ROE of -0.29%. Regarding short-term risk, 0RC7.L is less volatile compared to SNG.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs IXI.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, IXI.L has a market cap of 8.57M. Regarding current trading prices, 0RC7.L is priced at $84.70, while IXI.L trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas IXI.L's P/E ratio is -2.31. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to IXI.L's ROE of -0.21%. Regarding short-term risk, 0RC7.L is less volatile compared to IXI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs BVX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, BVX.L has a market cap of 8.25M. Regarding current trading prices, 0RC7.L is priced at $84.70, while BVX.L trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas BVX.L's P/E ratio is -2.50. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to BVX.L's ROE of -0.91%. Regarding short-term risk, 0RC7.L is more volatile compared to BVX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs HEMO.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, HEMO.L has a market cap of 7.48M. Regarding current trading prices, 0RC7.L is priced at $84.70, while HEMO.L trades at $182.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas HEMO.L's P/E ratio is -1.07. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to HEMO.L's ROE of -1.42%. Regarding short-term risk, 0RC7.L is more volatile compared to HEMO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OBD.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OBD.L has a market cap of 7.44M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OBD.L trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OBD.L's P/E ratio is -0.08. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OBD.L's ROE of -3.87%. Regarding short-term risk, 0RC7.L is less volatile compared to OBD.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs APTA.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, APTA.L has a market cap of 7.37M. Regarding current trading prices, 0RC7.L is priced at $84.70, while APTA.L trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas APTA.L's P/E ratio is -0.37. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to APTA.L's ROE of -1.31%. Regarding short-term risk, 0RC7.L is less volatile compared to APTA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs FAB.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, FAB.L has a market cap of 6.91M. Regarding current trading prices, 0RC7.L is priced at $84.70, while FAB.L trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas FAB.L's P/E ratio is -3.05. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to FAB.L's ROE of -1.14%. Regarding short-term risk, 0RC7.L is less volatile compared to FAB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs CIZ.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, CIZ.L has a market cap of 5.75M. Regarding current trading prices, 0RC7.L is priced at $84.70, while CIZ.L trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas CIZ.L's P/E ratio is -1.45. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to CIZ.L's ROE of -0.00%. Regarding short-term risk, 0RC7.L is less volatile compared to CIZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs TCF.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, TCF.L has a market cap of 5.05M. Regarding current trading prices, 0RC7.L is priced at $84.70, while TCF.L trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas TCF.L's P/E ratio is -0.23. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to TCF.L's ROE of -1.17%. Regarding short-term risk, 0RC7.L is less volatile compared to TCF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs GENF.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, GENF.L has a market cap of 3.91M. Regarding current trading prices, 0RC7.L is priced at $84.70, while GENF.L trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas GENF.L's P/E ratio is -1.00. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to GENF.L's ROE of -1.05%. Regarding short-term risk, 0RC7.L is less volatile compared to GENF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0QSS.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0QSS.L has a market cap of 3.62M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0QSS.L trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0QSS.L's P/E ratio is -0.21. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0QSS.L's ROE of -0.73%. Regarding short-term risk, 0RC7.L is less volatile compared to 0QSS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs EVG.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, EVG.L has a market cap of 3.50M. Regarding current trading prices, 0RC7.L is priced at $84.70, while EVG.L trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas EVG.L's P/E ratio is -0.82. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to EVG.L's ROE of -0.82%. Regarding short-term risk, 0RC7.L is more volatile compared to EVG.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0R02.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0R02.L has a market cap of 3.23M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0R02.L trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0R02.L's P/E ratio is -0.20. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0R02.L's ROE of -3.46%. Regarding short-term risk, 0RC7.L is more volatile compared to 0R02.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs DEST.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, DEST.L has a market cap of 2.87M. Regarding current trading prices, 0RC7.L is priced at $84.70, while DEST.L trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas DEST.L's P/E ratio is -0.50. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to DEST.L's ROE of -0.67%. Regarding short-term risk, 0RC7.L is more volatile compared to DEST.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ROQ.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ROQ.L has a market cap of 2.56M. Regarding current trading prices, 0RC7.L is priced at $84.70, while ROQ.L trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ROQ.L's P/E ratio is -1.65. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ROQ.L's ROE of -0.30%. Regarding short-term risk, 0RC7.L is less volatile compared to ROQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs NFX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, NFX.L has a market cap of 2.20M. Regarding current trading prices, 0RC7.L is priced at $84.70, while NFX.L trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas NFX.L's P/E ratio is N/A. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to NFX.L's ROE of -0.00%. Regarding short-term risk, 0RC7.L is less volatile compared to NFX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs VAL.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, VAL.L has a market cap of 2.06M. Regarding current trading prices, 0RC7.L is priced at $84.70, while VAL.L trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas VAL.L's P/E ratio is -0.28. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to VAL.L's ROE of -0.56%. Regarding short-term risk, 0RC7.L is less volatile compared to VAL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs RENE.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, RENE.L has a market cap of 1.93M. Regarding current trading prices, 0RC7.L is priced at $84.70, while RENE.L trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas RENE.L's P/E ratio is -0.38. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to RENE.L's ROE of -1.76%. Regarding short-term risk, 0RC7.L is more volatile compared to RENE.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0QNV.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0QNV.L has a market cap of 1.71M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0QNV.L trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0QNV.L's P/E ratio is -0.12. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0QNV.L's ROE of +0.88%. Regarding short-term risk, 0RC7.L is more volatile compared to 0QNV.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs CRTX.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, CRTX.L has a market cap of 1.50M. Regarding current trading prices, 0RC7.L is priced at $84.70, while CRTX.L trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas CRTX.L's P/E ratio is 0.02. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to CRTX.L's ROE of -0.13%. Regarding short-term risk, 0RC7.L is less volatile compared to CRTX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs ONC.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, ONC.L has a market cap of 1.27M. Regarding current trading prices, 0RC7.L is priced at $84.70, while ONC.L trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas ONC.L's P/E ratio is -0.23. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to ONC.L's ROE of +1.97%. Regarding short-term risk, 0RC7.L is less volatile compared to ONC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs PYC.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, PYC.L has a market cap of 1.26M. Regarding current trading prices, 0RC7.L is priced at $84.70, while PYC.L trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas PYC.L's P/E ratio is -0.41. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to PYC.L's ROE of -1.81%. Regarding short-term risk, 0RC7.L is less volatile compared to PYC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OCTP.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OCTP.L has a market cap of 1.25M. Regarding current trading prices, 0RC7.L is priced at $84.70, while OCTP.L trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OCTP.L's P/E ratio is -0.11. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OCTP.L's ROE of -0.87%. Regarding short-term risk, 0RC7.L is more volatile compared to OCTP.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0QGJ.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0QGJ.L has a market cap of 1.18M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0QGJ.L trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0QGJ.L's P/E ratio is -0.22. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0QGJ.L's ROE of -0.78%. Regarding short-term risk, 0RC7.L is less volatile compared to 0QGJ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0R55.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0R55.L has a market cap of 1.04M. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0R55.L trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0R55.L's P/E ratio is N/A. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0R55.L's ROE of +0.34%. Regarding short-term risk, 0RC7.L is less volatile compared to 0R55.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs OVB.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, OVB.L has a market cap of 937984.00. Regarding current trading prices, 0RC7.L is priced at $84.70, while OVB.L trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas OVB.L's P/E ratio is -0.29. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to OVB.L's ROE of -0.52%. Regarding short-term risk, 0RC7.L is more volatile compared to OVB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.
0RC7.L vs 0RGO.L Comparison
0RC7.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0RC7.L stands at 1.86B. In comparison, 0RGO.L has a market cap of 78712.00. Regarding current trading prices, 0RC7.L is priced at $84.70, while 0RGO.L trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0RC7.L currently has a P/E ratio of N/A, whereas 0RGO.L's P/E ratio is 0.10. In terms of profitability, 0RC7.L's ROE is +1.43%, compared to 0RGO.L's ROE of -0.11%. Regarding short-term risk, 0RC7.L is more volatile compared to 0RGO.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RC7.L.